Sfoglia per Autore
Prognostic value of pathologic complete response after primary chemotherapy in patients with hormone receptor-positive breast cancer.
2005 Guarneri, Valentina; K., Broglio; S., Kau; M., Cristofanilli; Au, Buzdar; V., Valero; T., Buchholz; F., Meric; L., Middleton; Gn, Hortobagyi; AM Gonzalez, Angulo
High dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transpalntation (EBMT)
2005 C., Bengala; Guarneri, Valentina; J., Ledermann; G., Rosti; H., Wandt; Jp, Lotz; Jh, Cure; C., Orlandini; P., Ferrante; Conte, Pierfranco; T., Demirer
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma
2005 C., Bengala; Guarneri, Valentina; E., Giovannetti; M., Lencioni; E., Fontana; V., Mey; A., Fontana; U., Boggi; M., Del Chiaro; R., Danesi; S., Ricci; F., Mosca; M., Del Tacca; Conte, Pierfranco
Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation
2005 Guarneri, Valentina; Frassoldati, A; Ficarra, G; Giovannelli, Simona; Borghi, F; Puglisi, F; Mansutti, M; Andreetta, C; Banna, G; Masci, G; Santoro, A; Boni, C; Bisagni, G; Michelotti, A; Crispino, S; Conte, Pierfranco
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA
2006 Guarneri, Valentina; Piacentini, F.; Jovic, G.; Frassoldati, A.; Ficarra, G.; Maiorana, A.; Giovannelli, S.; Tazzioli, G.; Natalizi, G.; Mauri, C.; Battista, R.; Canossi, B.; Conte, P. F.
CARCINOMI MAMMARI HER2 POSITIVI: CASISTICA DI MODENA
2006 Giovannelli, S.; Guarneri, V.; Ficarra, G.; Frassoldati, A.; Ferrari, Alessia; Piacentini, F.; Maiorana, A.; Conte, P. F.
Bone health: new horizons in the prevention of cancer-treatment induced bone loss and management of bone metastases.
2006 Guarneri, Valentina; Conte, Pierfranco
CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY
2006 Guarneri, V.; Piacentini, F.; Frassoldati, A.; Jovic, G.; Ficarra, G.; Maur, M.; Giovannelli, S.; Giardina, D.; Conte, P. F.
VALUTAZIONE DEL RISCHIO DI TOSSICITA’ CARDIACA DI TRASTUZUMAB IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO IN TRATTAMENTO ADIUVANTE
2006 Piacentini, F.; Guarneri, V.; Barbieri, E.; Frassoldati, A.; Giovannelli, S.; Conte, P. F.
Circulating tumor cells (CTCs) in metastatic breast cancer: Biological value beyond tumor burden.
2006 M., Cristofanilli; Guarneri, Valentina; V., Valero; H. A., Fritsche; K. R., Broglio; J. M., Reuben; J., Lara; S., Krishnamurthy; G. N., Hortobagyi
Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy.
2006 A. O., Hoff; B. B., Toth; K., Altundag; Guarneri, Valentina; A., Adamus; A. K., Nooka; G. G., Sayegh; M. M., Johnson; R. F., Gagel; G. N., Hortobagyi
Final results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarker evaluation in operable breast cancer
2006 Guarneri, Valentina; Frassoldati, A; Ficarra, G; Jovic, Gordana; Puglisi, F; Michelotti, A; Boni, C; Battelli, N; Santoro, A; Conte, Pierfranco
Downregulation of the Cyclin-Dependent Kinase Inhibitor p27kip1 Might Correlate with Poor Disease-Free and Overall Survival in Inflammatory Breast Cancer
2006 GONZALEZ ANGULO, Am; Guarneri, Valentina; Gong, Y; Cristofanilli, M; MORALES VASQUEZ, F; Sneige, N; Hortobagyi, Gn; Esteva, Fj
Clinical utility of measuring circulating tumor cells in metastatic breast cancer
2006 GUARNERI, Valentina; CRISTOFANILLI, M.
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study
2006 C., Bengala; C., Zamagni; P., Pedrazzoli; P., Matteucci; A., Ballestrero; G., DA PRADA; M., Martino; G., Rosti; M., Danova; M., Bregni; G., Jovic; Guarneri, Valentina; M., Maur; Conte, Pierfranco
Long term cardiac tolerability of trastuzumab in HER-2-overexpressing metastatic breast cancer (MBC).
2006 Guarneri, Valentina; D. J., Lenihan; V., Valero; J., Durand; K., Broglio; L., Boehnke Michaud; A. M., Gonzalez Angulo; G. N., Hortobagyi; F. J., Esteva
Primary Systemic Therapy in operable breast cancer: clinical data and biological fall-out
2006 Maur, M; Guarneri, Valentina; Frassoldati, A; Conte, Pierfranco
Biomarker expression and survival after primary chemotherapy for breast cancer.
2006 Guarneri, Valentina; Piacentini, Federico; Jovic, Gordana; Frassoldati, A; Ficarra, G; Giovannelli, Simona; Maur, M; Borghi, F; Vicini, Roberto; Conte, Pierfranco
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
2006 Guarneri, Valentina; K., Broglio; Sw, Kau; M., Cristofanilli; Au, Buzdar; V., Valero; T., Buchholz; F., Meric; L., Middleton; Gn, Hortobagyi; AM Gonzalez, Angulo
Long term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience
2006 Guarneri, Valentina; Lenihan, Dj; Valero, V; Durand, Jb; Broglio, K; Hess, Kr; Michaud, Lb; GONZALEZ ANGULO, Am; Hortobagyi, Gn; Esteva, Fj
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Prognostic value of pathologic complete response after primary chemotherapy in patients with hormone receptor-positive breast cancer. | 1-gen-2005 | Guarneri, Valentina; K., Broglio; S., Kau; M., Cristofanilli; Au, Buzdar; V., Valero; T., Buchholz; F., Meric; L., Middleton; Gn, Hortobagyi; AM Gonzalez, Angulo | |
High dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transpalntation (EBMT) | 1-gen-2005 | C., Bengala; Guarneri, Valentina; J., Ledermann; G., Rosti; H., Wandt; Jp, Lotz; Jh, Cure; C., Orlandini; P., Ferrante; Conte, Pierfranco; T., Demirer | |
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma | 1-gen-2005 | C., Bengala; Guarneri, Valentina; E., Giovannetti; M., Lencioni; E., Fontana; V., Mey; A., Fontana; U., Boggi; M., Del Chiaro; R., Danesi; S., Ricci; F., Mosca; M., Del Tacca; Conte, Pierfranco | |
Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation | 1-gen-2005 | Guarneri, Valentina; Frassoldati, A; Ficarra, G; Giovannelli, Simona; Borghi, F; Puglisi, F; Mansutti, M; Andreetta, C; Banna, G; Masci, G; Santoro, A; Boni, C; Bisagni, G; Michelotti, A; Crispino, S; Conte, Pierfranco | |
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA | 1-gen-2006 | Guarneri, Valentina; Piacentini, F.; Jovic, G.; Frassoldati, A.; Ficarra, G.; Maiorana, A.; Giovannelli, S.; Tazzioli, G.; Natalizi, G.; Mauri, C.; Battista, R.; Canossi, B.; Conte, P. F. | |
CARCINOMI MAMMARI HER2 POSITIVI: CASISTICA DI MODENA | 1-gen-2006 | Giovannelli, S.; Guarneri, V.; Ficarra, G.; Frassoldati, A.; Ferrari, Alessia; Piacentini, F.; Maiorana, A.; Conte, P. F. | |
Bone health: new horizons in the prevention of cancer-treatment induced bone loss and management of bone metastases. | 1-gen-2006 | Guarneri, Valentina; Conte, Pierfranco | |
CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY | 1-gen-2006 | Guarneri, V.; Piacentini, F.; Frassoldati, A.; Jovic, G.; Ficarra, G.; Maur, M.; Giovannelli, S.; Giardina, D.; Conte, P. F. | |
VALUTAZIONE DEL RISCHIO DI TOSSICITA’ CARDIACA DI TRASTUZUMAB IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO IN TRATTAMENTO ADIUVANTE | 1-gen-2006 | Piacentini, F.; Guarneri, V.; Barbieri, E.; Frassoldati, A.; Giovannelli, S.; Conte, P. F. | |
Circulating tumor cells (CTCs) in metastatic breast cancer: Biological value beyond tumor burden. | 1-gen-2006 | M., Cristofanilli; Guarneri, Valentina; V., Valero; H. A., Fritsche; K. R., Broglio; J. M., Reuben; J., Lara; S., Krishnamurthy; G. N., Hortobagyi | |
Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy. | 1-gen-2006 | A. O., Hoff; B. B., Toth; K., Altundag; Guarneri, Valentina; A., Adamus; A. K., Nooka; G. G., Sayegh; M. M., Johnson; R. F., Gagel; G. N., Hortobagyi | |
Final results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarker evaluation in operable breast cancer | 1-gen-2006 | Guarneri, Valentina; Frassoldati, A; Ficarra, G; Jovic, Gordana; Puglisi, F; Michelotti, A; Boni, C; Battelli, N; Santoro, A; Conte, Pierfranco | |
Downregulation of the Cyclin-Dependent Kinase Inhibitor p27kip1 Might Correlate with Poor Disease-Free and Overall Survival in Inflammatory Breast Cancer | 1-gen-2006 | GONZALEZ ANGULO, Am; Guarneri, Valentina; Gong, Y; Cristofanilli, M; MORALES VASQUEZ, F; Sneige, N; Hortobagyi, Gn; Esteva, Fj | |
Clinical utility of measuring circulating tumor cells in metastatic breast cancer | 1-gen-2006 | GUARNERI, Valentina; CRISTOFANILLI, M. | |
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study | 1-gen-2006 | C., Bengala; C., Zamagni; P., Pedrazzoli; P., Matteucci; A., Ballestrero; G., DA PRADA; M., Martino; G., Rosti; M., Danova; M., Bregni; G., Jovic; Guarneri, Valentina; M., Maur; Conte, Pierfranco | |
Long term cardiac tolerability of trastuzumab in HER-2-overexpressing metastatic breast cancer (MBC). | 1-gen-2006 | Guarneri, Valentina; D. J., Lenihan; V., Valero; J., Durand; K., Broglio; L., Boehnke Michaud; A. M., Gonzalez Angulo; G. N., Hortobagyi; F. J., Esteva | |
Primary Systemic Therapy in operable breast cancer: clinical data and biological fall-out | 1-gen-2006 | Maur, M; Guarneri, Valentina; Frassoldati, A; Conte, Pierfranco | |
Biomarker expression and survival after primary chemotherapy for breast cancer. | 1-gen-2006 | Guarneri, Valentina; Piacentini, Federico; Jovic, Gordana; Frassoldati, A; Ficarra, G; Giovannelli, Simona; Maur, M; Borghi, F; Vicini, Roberto; Conte, Pierfranco | |
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors | 1-gen-2006 | Guarneri, Valentina; K., Broglio; Sw, Kau; M., Cristofanilli; Au, Buzdar; V., Valero; T., Buchholz; F., Meric; L., Middleton; Gn, Hortobagyi; AM Gonzalez, Angulo | |
Long term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience | 1-gen-2006 | Guarneri, Valentina; Lenihan, Dj; Valero, V; Durand, Jb; Broglio, K; Hess, Kr; Michaud, Lb; GONZALEZ ANGULO, Am; Hortobagyi, Gn; Esteva, Fj |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile